John D. Roback

10.4k total citations · 2 hit papers
181 papers, 6.0k citations indexed

About

John D. Roback is a scholar working on Hematology, Physiology and Biochemistry. According to data from OpenAlex, John D. Roback has authored 181 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Hematology, 51 papers in Physiology and 36 papers in Biochemistry. Recurrent topics in John D. Roback's work include Blood groups and transfusion (53 papers), Erythrocyte Function and Pathophysiology (48 papers) and Blood transfusion and management (36 papers). John D. Roback is often cited by papers focused on Blood groups and transfusion (53 papers), Erythrocyte Function and Pathophysiology (48 papers) and Blood transfusion and management (36 papers). John D. Roback collaborates with scholars based in United States, Canada and Japan. John D. Roback's co-authors include Christopher D. Hillyer, Cassandra D. Josephson, James C. Zimring, Aryeh Shander, Mark Fung, Brenda J. Grossman, Sunil V. Rao, Lewis J. Kaplan, John B. Holcomb and Louis M. Katz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Neuroscience.

In The Last Decade

John D. Roback

173 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB*

2012 739 citations John D. Roback et al. Annals of Internal Medicine profile →
Clinical Practice Guidelines From the AABB

2016 700 citations Nancy M. Heddle, Claudia S. Cohn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John D. Roback United States	40	1.9k	1.8k	1.1k	992	832	181	6.0k
Hannah Cohen United Kingdom	48	1.2k 0.6×	3.7k 2.1×	337 0.3×	576 0.6×	805 1.0×	195	9.4k
Eldad A. Hod United States	40	996 0.5×	1.5k 0.9×	1.4k 1.3×	241 0.2×	805 1.0×	127	5.3k
James C. Zimring United States	46	1.3k 0.7×	2.8k 1.6×	3.1k 2.9×	236 0.2×	1.2k 1.4×	193	6.4k
Christopher C. Silliman United States	61	5.3k 2.8×	1.9k 1.1×	1.4k 1.3×	6.1k 6.1×	661 0.8×	311	13.5k
Kenneth A. Ault United States	47	407 0.2×	2.0k 1.2×	688 0.6×	137 0.1×	788 0.9×	102	7.3k
Alan E. Mast United States	41	358 0.2×	3.3k 1.9×	418 0.4×	95 0.1×	2.1k 2.6×	141	5.5k
Yves Béguin Belgium	51	375 0.2×	4.7k 2.6×	685 0.6×	48 0.0×	3.4k 4.1×	368	9.4k
Timothy A. Pritts United States	37	337 0.2×	172 0.1×	428 0.4×	672 0.7×	77 0.1×	193	3.9k
Michael Gregor Germany	50	99 0.1×	870 0.5×	433 0.4×	129 0.1×	596 0.7×	200	7.7k
Isadore Brodsky United States	31	253 0.1×	1.0k 0.6×	176 0.2×	163 0.2×	397 0.5×	152	3.2k

Countries citing papers authored by John D. Roback

Since Specialization

Citations

This map shows the geographic impact of John D. Roback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Roback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Roback more than expected).

Fields of papers citing papers by John D. Roback

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Roback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Roback. The network helps show where John D. Roback may publish in the future.

Co-authorship network of co-authors of John D. Roback

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Roback. A scholar is included among the top collaborators of John D. Roback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Roback. John D. Roback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yee, Marianne E., Patricia E. Zerra, James McCoy, et al.. (2024). Post‐transfusion biotin‐labeled red blood cell survival studies in pediatric sickle cell disease with antibodies of uncertain significance. Transfusion. 64(5). 800–807. 1 indexed citations

Cheedarla, Narayanaiah, et al.. (2023). COVID-19 vaccine induced poor neutralization titers for SARS-CoV-2 omicron variants in maternal and cord blood. Frontiers in Immunology. 14. 1211558–1211558. 3 indexed citations

Wu, Shang‐Chuen, Connie M. Arthur, Wilfredo F. García-Beltrán, et al.. (2023). Blood group A enhances SARS-CoV-2 infection. Blood. 142(8). 742–747. 22 indexed citations

Cheedarla, Narayanaiah, Hans Verkerke, Shang‐Chuen Wu, et al.. (2023). Enhanced IgG immune response to COVID‐19 vaccination in patients with sickle cell disease. British Journal of Haematology. 202(5). 937–941. 5 indexed citations

Sobhani, Kimia, Susan Cheng, Raquel A. Binder, et al.. (2023). Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection. Vaccines. 11(11). 1644–1644. 16 indexed citations

Jajosky, Ryan Philip, Kashyap Patel, Patricia E. Zerra, et al.. (2023). Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression. Blood. 142(12). 1082–1098. 17 indexed citations

Roback, John D., et al.. (2023). Three patients highlighting potential pitfalls in platelet refractory testing. Transfusion. 63(4). 888–892. 1 indexed citations

Zhang, Hanwen, Khanjan Gandhi, Sruthi Ravindranathan, et al.. (2022). Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression. Blood. 140(12). 1431–1447. 9 indexed citations

Arthur, Connie M., Seema R. Patel, Patricia E. Zerra, et al.. (2022). Clodronate inhibits alloimmunization against distinct red blood cell alloantigens in mice. Transfusion. 62(5). 948–953. 12 indexed citations

10.

Denomme, Gregory A., et al.. (2022). A case of Tn polyagglutination discovered by an ABO blood group discrepancy. Transfusion. 62(7). 1452–1456. 1 indexed citations

11.

Yee, Marianne E., Richard O. Francis, Naomi L.C. Luban, et al.. (2022). Glucose‐6‐phosphate dehydrogenase deficiency is more prevalent in Duffy‐null red blood cell transfusion in sickle cell disease. Transfusion. 62(3). 551–555. 4 indexed citations

12.

Wu, Shang‐Chuen, Connie M. Arthur, Jianmei Wang, et al.. (2021). The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A. Blood Advances. 5(5). 1305–1309. 67 indexed citations

13.

Arthur, Connie M., Hans Verkerke, Ryan Philip Jajosky, et al.. (2021). Antigen density dictates RBC clearance, but not antigen modulation, following incompatible RBC transfusion in mice. Blood Advances. 5(2). 527–538. 16 indexed citations

14.

Zerra, Patricia E., Seema R. Patel, Ryan Philip Jajosky, et al.. (2021). Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice. Blood. 138(8). 706–721. 38 indexed citations

15.

Baker, Julia M., Kristin N. Nelson, Elizabeth Overton, et al.. (2021). Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System. Annals of Internal Medicine. 174(5). 649–654. 57 indexed citations

16.

Howie, Heather L., Ariel Hay, Hayley R. Waterman, et al.. (2019). Differences in Steap3 expression are a mechanism of genetic variation of RBC storage and oxidative damage in mice. Blood Advances. 3(15). 2272–2285. 67 indexed citations

17.

Cushing, Melissa M., James Kelley, Ellen Klapper, et al.. (2018). Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee. Transfusion. 58(4). 1065–1075. 2 indexed citations

18.

Hossain, Mohammad Salim, John D. Roback, Feng‐Rong Wang, & Edmund K. Waller. (2008). Host and Donor Immune Responses Contribute to Antiviral Effects of Amotosalen-Treated Donor Lymphocytes following Early Posttransplant Cytomegalovirus Infection. The Journal of Immunology. 180(10). 6892–6902. 11 indexed citations

19.

Roback, John D., Maureen G. Conlan, W. Lawrence Drew, et al.. (2005). The Role of Photochemical Treatment With Amotosalen and UV-A Light in the Prevention of Transfusion-Transmitted Cytomegalovirus Infections. Transfusion Medicine Reviews. 20(1). 45–56. 24 indexed citations

20.

Roback, John D., MM Hossain, David L. Jaye, et al.. (2003). Allogeneic T Cells Treated with Amotosalen Prevent Lethal Cytomegalovirus Disease without Producing Graft-versus-Host Disease Following Bone Marrow Transplantation. The Journal of Immunology. 171(11). 6023–6031. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact